What is Sugarbreak?
Sugarbreak offers a non-prescription support system formulated with natural ingredients designed to help individuals curb sugar intake and manage blood sugar levels. The company's mission is to address the rising global trends of obesity and diabetes, which are often linked to elevated blood sugar. Operating independently of the pharmaceutical sector, Sugarbreak collaborates with leading scientists and clinicians to provide evidence-based solutions. Their product aims to be a natural, effective, safe, and accessible alternative for blood sugar management, empowering users to achieve and maintain optimal health.
How much funding has Sugarbreak raised?
Sugarbreak has raised a total of $3M across 1 funding round:
Other Financing Round
$3M
Other Financing Round (2020): $3M with participation from BBG Ventures, SKAGEN Conscience Capital, Sorven Capital, and Bronze
Key Investors in Sugarbreak
BBG Ventures
BBG Ventures is a venture capital firm that invests in visionary entrepreneurs building the next generation of market-defining consumer products and services, with a specific focus on backing companies founded by women.
SKAGEN Conscience Capital
SKAGEN Conscience Capital is an investment firm that likely focuses on companies with a strong ethical or sustainable business model, aligning with conscious consumer trends.
Sorven Capital
Sorven Capital is an investment entity that may focus on diverse sectors, potentially including consumer health or innovative wellness solutions, given its participation in Sugarbreak's funding.
What's next for Sugarbreak?
The recent major strategic investment in Sugarbreak indicates a pivotal moment for the company, likely enabling accelerated product development, expanded market reach, and enhanced scientific research. With a focus on natural ingredients and evidence-based solutions, Sugarbreak is well-positioned to capitalize on the growing consumer demand for health and wellness products that address metabolic health. Future growth may involve scaling production, forging new partnerships, and further clinical validation to solidify its position as a leader in the natural blood sugar management market.
See full Sugarbreak company page
